Cargando…
Chronic Infection with Hepatitis C Virus Subtype 1g in a Japanese Patient Successfully Treated with Glecaprevir/Pibrentasvir
A 66-year-old man, who had undergone plasma exchange 30 years previously in Egypt for the treatment of falciparum malaria, was referred to our hospital for treatment of chronic hepatitis C (HCV). An analysis of the 655-nucleotide 5′-untranslated region-core region sequence revealed infection with HC...
Autores principales: | Hatanaka, Takeshi, Kakizaki, Satoru, Kaburagi, Takuya, Saito, Naoto, Nakano, Sachi, Hazama, Yoichi, Yoshida, Sachiko, Hachisu, Yoko, Tanaka, Yoshiki, Yoshinaga, Teruo, Kashiwabara, Kenji, Naganuma, Atsushi, Yamazaki, Yuichi, Uraoka, Toshio, Nagashima, Shigeo, Takahashi, Masaharu, Nishizawa, Tsutomu, Murata, Kazumoto, Okamoto, Hiroaki |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
The Japanese Society of Internal Medicine
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9177357/ https://www.ncbi.nlm.nih.gov/pubmed/34897154 http://dx.doi.org/10.2169/internalmedicine.8673-21 |
Ejemplares similares
-
Impact of Pemafibrate in Patients with Hypertriglyceridemia and Metabolic Dysfunction-associated Fatty Liver Disease Pathologically Diagnosed with Non-alcoholic Steatohepatitis: A Retrospective, Single-arm Study
por: Hatanaka, Takeshi, et al.
Publicado: (2021) -
A case of unresectable combined hepatocellular and cholangiocarcinoma treated with atezolizumab plus bevacizumab
por: Saito, Naoto, et al.
Publicado: (2022) -
Relationship between Being Overweight and Clinical Outcomes of Ablation Therapy for Hepatocellular Carcinoma under Ultrasound Guidance: A Retrospective Analysis
por: Hatanaka, Takeshi, et al.
Publicado: (2023) -
Nationwide registry of glecaprevir plus pibrentasvir in the treatment of HCV in Taiwan
por: Huang, Chung-Feng, et al.
Publicado: (2021) -
Efficacy and Safety of Glecaprevir/Pibrentasvir in Patients with Chronic HCV Infection
por: Liu, Xiaoqing, et al.
Publicado: (2021)